Valley National Advisers Inc. Sells 3,598 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Valley National Advisers Inc. decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 15.3% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 19,901 shares of the exchange traded fund’s stock after selling 3,598 shares during the quarter. Valley National Advisers Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,966,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Modera Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 14.5% in the 3rd quarter. Modera Wealth Management LLC now owns 23,489 shares of the exchange traded fund’s stock valued at $2,321,000 after buying an additional 2,975 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in SPDR S&P Biotech ETF by 4.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 118,563 shares of the exchange traded fund’s stock worth $11,714,000 after purchasing an additional 4,625 shares in the last quarter. Masso Torrence Wealth Management Inc. boosted its stake in SPDR S&P Biotech ETF by 0.9% in the third quarter. Masso Torrence Wealth Management Inc. now owns 26,221 shares of the exchange traded fund’s stock worth $2,591,000 after purchasing an additional 228 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in SPDR S&P Biotech ETF by 16.3% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,390 shares of the exchange traded fund’s stock worth $2,113,000 after purchasing an additional 2,997 shares in the last quarter. Finally, Osborne Partners Capital Management LLC boosted its stake in SPDR S&P Biotech ETF by 1.3% in the third quarter. Osborne Partners Capital Management LLC now owns 94,007 shares of the exchange traded fund’s stock worth $9,288,000 after purchasing an additional 1,165 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $97.15 on Friday. The firm has a market cap of $7.40 billion, a P/E ratio of 11.47 and a beta of 1.11. The business’s fifty day moving average is $99.14 and its two-hundred day moving average is $94.62. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.